Shelter Pharma revenue climbs 44% to ₹73.13 crore
The Ahmedabad-based firm grew annual net profit by 25% to ₹9.03 crore for FY26, as the board appointed a new internal auditor.
What's new
- Annual revenue rose 44% to ₹73.13 crore.
- Net profit increased 25% to ₹9.03 crore.
- CA Ismail Ibrahimbhai Lakhani appointed as internal auditor for FY27.
Why this matters
For a company with a market valuation of ₹51 crore, this growth shows meaningful scaling. The bottom-line expansion confirms that the firm is managing its profitability alongside its top-line gains.
What we're watching
- Whether the company maintains this growth pace in FY27.
- The impact of the new internal auditor on financial reporting processes.
- Any further expansion plans for the current fiscal year.
The full read
Shelter Pharma delivered a strong performance for the fiscal year ended March 31, 2026. Annual revenue jumped 44% to ₹73.13 crore, while net profit grew 25% to ₹9.03 crore from ₹7.24 crore in the previous year. Earnings per share also ticked up to ₹6.57 from ₹6.26.
For a company with a market valuation of just ₹51 crore, these results indicate rapid operational expansion. The board also moved to strengthen its oversight by appointing CA Ismail Ibrahimbhai Lakhani as the internal auditor for FY27. These figures provide a clear picture of the company’s recent scaling efforts and its ability to maintain bottom-line stability while growing its top line.
Growth is clear. The next test is whether this momentum persists into the current fiscal year.
Questions answered
- How did Shelter Pharma's profit compare to the previous year?
- Net profit reached ₹9.03 crore for FY26, up from ₹7.24 crore in the previous fiscal year.
- What was the change in earnings per share?
- Earnings per share rose to ₹6.57 for FY26, compared to ₹6.26 in the prior year.
- Who is the new internal auditor?
- The board appointed CA Ismail Ibrahimbhai Lakhani to serve as the internal auditor for the 2026-27 financial year.
- What is the company's current market valuation?
- Shelter Pharma has a market valuation of approximately ₹51 crore.